Luke O’Neill, Trinity College, Ireland
Professor Luke O’Neill

Professor Luke O’Neill was appointed to the Chair of Biochemistry at Trinity College Dublin in 2008, where he leads the Inflammation Research Group. He has a PhD in Pharmacology from the University of London and carried out Post-Doctoral research at Cambridge U.K. on the pro-inflammatory cytokine IL-1 and innate immune signaling. His research is in the area of the molecular basis to inflammatory diseases, with a particular interest in Toll-like receptors, inflammasomes and metabolic control of inflammatory cell signaling. He has won numerous awards for his research, notably the Royal Irish Academy Medal for Biochemistry, the Royal Dublin Society/ Irish Times Boyle medal for Scientific Excellence in 2014 the European Federation of Immunology Societies Medal. He was elected a member of EMBO in 2005. In 2015 he was named by Thompson Reuters as one of the world’s most influential scientists, being in the top 1% in Immunology. He is a European Research Council Advanced Grant Holder and is co-founder and director of Opsona Therapeutics, a drug development company working in the area of Toll-like receptors.

« Go Back

Register Here Submit Abstract
Supporting Publications
In partnership with
Under the high patronage of
Premier Sponsor
Gold Sponsor